10 20 30 40 50 60 70 80 1FL1 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER VIRAL PROTEIN 11-AUG-00 1FL1
TITLE KSHV PROTEASE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN HERPESVIRUS 8; SOURCE 3 ORGANISM_TAXID: 37296; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PQE30
KEYWDS SERINE PROTEASE, ANTIVIRAL DRUG DESIGN, CAPSID MATURATION, KEYWDS 2 ENDOPEPTIDASE, ASSEMBLIN, VIRAL PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR K.K.REILING,T.R.PRAY,C.S.CRAIK,R.M.STROUD
REVDAT 2 24-FEB-09 1FL1 1 VERSN REVDAT 1 22-NOV-00 1FL1 0
JRNL AUTH K.K.REILING,T.R.PRAY,C.S.CRAIK,R.M.STROUD JRNL TITL FUNCTIONAL CONSEQUENCES OF THE KAPOSI'S JRNL TITL 2 SARCOMA-ASSOCIATED HERPESVIRUS PROTEASE STRUCTURE: JRNL TITL 3 REGULATION OF ACTIVITY AND DIMERIZATION BY JRNL TITL 4 CONSERVED STRUCTURAL ELEMENTS. JRNL REF BIOCHEMISTRY V. 39 12796 2000 JRNL REFN ISSN 0006-2960 JRNL PMID 11041844 JRNL DOI 10.1021/BI001019H
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.T.BRUNGER,P.D.ADAMS,G.M.CLORE,W.L.DELANO,P.GROS, REMARK 1 AUTH 2 R.GROSSE-KUNSTLEVE,J.-S.JIANG,J.KUSZEWSKI,M.NILGES, REMARK 1 AUTH 3 N.S.PANNU,R.J.READ,L.M.RICE,T.SIMONSON,G.WARREN REMARK 1 TITL CRYSTALLOGRAPHY & NMR SYSTEM: A NEW SOFTWARE SUITE REMARK 1 TITL 2 FOR MACROMOLECULAR STRUCTURE DETERMINATION REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 54 905 1998 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444998003254
REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : CAMBRIDGE DATA BASE MODEL STRUCTURES (R. REMARK 3 A. ENGH AND R. HUBER, ACTA CRYST. SECT. A., REMARK 3 1991). REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 27951 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.225 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1642 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2987 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 1 REMARK 3 SOLVENT ATOMS : 195 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.66 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.561 REMARK 3 BOND ANGLES (DEGREES) : 3.80 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES 182 AND 207 HAD DENSITY REMARK 3 ONLY TO THE CG AND WERE MODELED AS SERINES DURING REFINEMENT.
REMARK 4 REMARK 4 1FL1 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-OCT-00. REMARK 100 THE RCSB ID CODE IS RCSB011677.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-AUG-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28034 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 28.282 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.22 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.35100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22% PEG-2K, 100 MM TRIS-HCL, 10% REMARK 280 GLYCEROL, 190 MM LISO4, PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 25K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 107.68667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 215.37333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 215.37333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 107.68667 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ACTIVE ENZYME IS A HOMO-DIMER CONSTRUCTED REMARK 300 FROM CHAIN A AND B RELATED BY A NON-CRYSTALOGRAPHIC TWO-FOLD.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6750 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 33150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -57.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 80.37000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 46.40164 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 107.68667
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 CYS A 16 REMARK 465 PRO A 17 REMARK 465 LYS A 18 REMARK 465 LEU A 19 REMARK 465 GLU A 20 REMARK 465 GLN A 21 REMARK 465 GLU A 22 REMARK 465 LEU A 23 REMARK 465 TYR A 24 REMARK 465 LEU A 25 REMARK 465 ASP A 26 REMARK 465 PRO A 27 REMARK 465 ASP A 28 REMARK 465 GLN A 29 REMARK 465 VAL A 30 REMARK 465 THR A 31 REMARK 465 ASP A 32 REMARK 465 TYR A 33 REMARK 465 LEU A 34 REMARK 465 PRO A 35 REMARK 465 VAL A 36 REMARK 465 THR A 37 REMARK 465 SER A 117 REMARK 465 ILE A 118 REMARK 465 HIS A 119 REMARK 465 PRO A 120 REMARK 465 ARG A 121 REMARK 465 GLU A 122 REMARK 465 LEU A 123 REMARK 465 SER A 124 REMARK 465 GLN A 125 REMARK 465 THR A 126 REMARK 465 PRO A 127 REMARK 465 SER A 128 REMARK 465 GLY A 129 REMARK 465 PRO A 130 REMARK 465 VAL A 131 REMARK 465 MET B 1 REMARK 465 SER B 15 REMARK 465 CYS B 16 REMARK 465 PRO B 17 REMARK 465 LYS B 18 REMARK 465 LEU B 19 REMARK 465 GLU B 20 REMARK 465 GLN B 21 REMARK 465 GLU B 22 REMARK 465 LEU B 23 REMARK 465 TYR B 24 REMARK 465 LEU B 25 REMARK 465 ASP B 26 REMARK 465 PRO B 27 REMARK 465 ARG B 121 REMARK 465 GLU B 122 REMARK 465 LEU B 123 REMARK 465 SER B 124 REMARK 465 GLN B 125 REMARK 465 THR B 126 REMARK 465 PRO B 127 REMARK 465 SER B 128 REMARK 465 GLY B 129
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 14 CG1 CG2 REMARK 470 SER A 15 OG REMARK 470 GLU A 38 CG CD OE1 OE2 REMARK 470 GLU A 78 CG CD OE1 OE2 REMARK 470 LYS A 95 CG CD CE NZ REMARK 470 ARG A 142 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 180 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 182 CG CD OE1 OE2 REMARK 470 ASP A 183 CG OD1 OD2 REMARK 470 ARG A 207 CG CD NE CZ NH1 NH2 REMARK 470 ALA B 2 CB REMARK 470 ASP B 28 CG OD1 OD2 REMARK 470 THR B 31 OG1 CG2 REMARK 470 GLU B 78 CG CD OE1 OE2 REMARK 470 ARG B 91 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 95 CG CD CE NZ REMARK 470 HIS B 119 CB CG ND1 CD2 CE1 NE2 REMARK 470 ARG B 143 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 180 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 182 CD OE1 OE2 REMARK 470 ARG B 207 CD NE CZ NH1 NH2
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 K K B 1001 K K B 1001 6765 0.96 REMARK 500 O HOH A 290 O HOH A 290 5555 2.04 REMARK 500 O HOH B 1064 O HOH B 1064 6765 2.08 REMARK 500 NE2 HIS B 171 K K B 1001 6765 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 HIS B 119 C - N - CA ANGL. DEV. = -19.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 3 -74.49 -94.15 REMARK 500 LYS A 95 -88.40 -105.68 REMARK 500 THR A 146 33.80 -91.42 REMARK 500 GLU A 182 36.51 -67.33 REMARK 500 ASP A 183 15.49 -156.54 REMARK 500 ASP B 32 -5.03 -173.36 REMARK 500 LYS B 95 -89.37 -103.75 REMARK 500 THR B 146 39.61 -96.81 REMARK 500 SER B 191 140.55 -38.13 REMARK 500 REMARK 500 REMARK: NULL
REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 K B1001 K REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 175 NE2 REMARK 620 2 HIS B 171 NE2 110.3 REMARK 620 3 HIS B 171 NE2 133.3 78.7 REMARK 620 4 HIS B 175 NE2 127.1 97.3 95.0 REMARK 620 N 1 2 3
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K B 1001
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AT3 RELATED DB: PDB REMARK 900 HERPES SIMPLEX VIRUS TYPE II PROTEASE REMARK 900 RELATED ID: 1VZV RELATED DB: PDB REMARK 900 VARICELLA-ZOSTER VIRUS PROTEASE REMARK 900 RELATED ID: 1CMV RELATED DB: PDB REMARK 900 HUMAN CYTOMEGALOVIRUS PROTEASE REMARK 900 RELATED ID: 1WPO RELATED DB: PDB REMARK 900 HUMAN CYTOMEGALOVIRUS PROTEASE - INHIBITED REMARK 900 RELATED ID: 1LAY RELATED DB: PDB REMARK 900 HUMAN CYTOMEGALOVIRUS PROTEASE
DBREF 1FL1 A 1 230 UNP O36607 O36607_HHV8 1 230 DBREF 1FL1 B 1 230 UNP O36607 O36607_HHV8 1 230
SEQADV 1FL1 GLY A 204 UNP O36607 SER 204 ENGINEERED SEQADV 1FL1 GLY B 204 UNP O36607 SER 204 ENGINEERED
SEQRES 1 A 230 MET ALA GLN GLY LEU TYR VAL GLY GLY PHE VAL ASP VAL SEQRES 2 A 230 VAL SER CYS PRO LYS LEU GLU GLN GLU LEU TYR LEU ASP SEQRES 3 A 230 PRO ASP GLN VAL THR ASP TYR LEU PRO VAL THR GLU PRO SEQRES 4 A 230 LEU PRO ILE THR ILE GLU HIS LEU PRO GLU THR GLU VAL SEQRES 5 A 230 GLY TRP THR LEU GLY LEU PHE GLN VAL SER HIS GLY ILE SEQRES 6 A 230 PHE CYS THR GLY ALA ILE THR SER PRO ALA PHE LEU GLU SEQRES 7 A 230 LEU ALA SER ARG LEU ALA ASP THR SER HIS VAL ALA ARG SEQRES 8 A 230 ALA PRO VAL LYS ASN LEU PRO LYS GLU PRO LEU LEU GLU SEQRES 9 A 230 ILE LEU HIS THR TRP LEU PRO GLY LEU SER LEU SER SER SEQRES 10 A 230 ILE HIS PRO ARG GLU LEU SER GLN THR PRO SER GLY PRO SEQRES 11 A 230 VAL PHE GLN HIS VAL SER LEU CYS ALA LEU GLY ARG ARG SEQRES 12 A 230 ARG GLY THR VAL ALA VAL TYR GLY HIS ASP ALA GLU TRP SEQRES 13 A 230 VAL VAL SER ARG PHE SER SER VAL SER LYS SER GLU ARG SEQRES 14 A 230 ALA HIS ILE LEU GLN HIS VAL SER SER CYS ARG LEU GLU SEQRES 15 A 230 ASP LEU SER THR PRO ASN PHE VAL SER PRO LEU GLU THR SEQRES 16 A 230 LEU MET ALA LYS ALA ILE ASP ALA GLY PHE ILE ARG ASP SEQRES 17 A 230 ARG LEU ASP LEU LEU LYS THR ASP ARG GLY VAL ALA SER SEQRES 18 A 230 ILE LEU SER PRO VAL TYR LEU LYS ALA SEQRES 1 B 230 MET ALA GLN GLY LEU TYR VAL GLY GLY PHE VAL ASP VAL SEQRES 2 B 230 VAL SER CYS PRO LYS LEU GLU GLN GLU LEU TYR LEU ASP SEQRES 3 B 230 PRO ASP GLN VAL THR ASP TYR LEU PRO VAL THR GLU PRO SEQRES 4 B 230 LEU PRO ILE THR ILE GLU HIS LEU PRO GLU THR GLU VAL SEQRES 5 B 230 GLY TRP THR LEU GLY LEU PHE GLN VAL SER HIS GLY ILE SEQRES 6 B 230 PHE CYS THR GLY ALA ILE THR SER PRO ALA PHE LEU GLU SEQRES 7 B 230 LEU ALA SER ARG LEU ALA ASP THR SER HIS VAL ALA ARG SEQRES 8 B 230 ALA PRO VAL LYS ASN LEU PRO LYS GLU PRO LEU LEU GLU SEQRES 9 B 230 ILE LEU HIS THR TRP LEU PRO GLY LEU SER LEU SER SER SEQRES 10 B 230 ILE HIS PRO ARG GLU LEU SER GLN THR PRO SER GLY PRO SEQRES 11 B 230 VAL PHE GLN HIS VAL SER LEU CYS ALA LEU GLY ARG ARG SEQRES 12 B 230 ARG GLY THR VAL ALA VAL TYR GLY HIS ASP ALA GLU TRP SEQRES 13 B 230 VAL VAL SER ARG PHE SER SER VAL SER LYS SER GLU ARG SEQRES 14 B 230 ALA HIS ILE LEU GLN HIS VAL SER SER CYS ARG LEU GLU SEQRES 15 B 230 ASP LEU SER THR PRO ASN PHE VAL SER PRO LEU GLU THR SEQRES 16 B 230 LEU MET ALA LYS ALA ILE ASP ALA GLY PHE ILE ARG ASP SEQRES 17 B 230 ARG LEU ASP LEU LEU LYS THR ASP ARG GLY VAL ALA SER SEQRES 18 B 230 ILE LEU SER PRO VAL TYR LEU LYS ALA
HET K B1001 1
HETNAM K POTASSIUM ION
FORMUL 3 K K 1+ FORMUL 4 HOH *169(H2 O)
HELIX 1 1 SER A 73 SER A 87 1 15 HELIX 2 2 HIS A 88 ARG A 91 5 4 HELIX 3 3 GLU A 100 LEU A 110 1 11 HELIX 4 4 ASP A 153 ARG A 160 1 8 HELIX 5 5 SER A 165 SER A 178 1 14 HELIX 6 6 PRO A 192 GLY A 204 1 13 HELIX 7 7 ASP A 208 SER A 221 1 14 HELIX 8 8 SER B 73 SER B 87 1 15 HELIX 9 9 HIS B 88 ARG B 91 5 4 HELIX 10 10 GLU B 100 LEU B 110 1 11 HELIX 11 11 ASP B 153 ARG B 160 1 8 HELIX 12 12 SER B 165 SER B 178 1 14 HELIX 13 13 ARG B 180 LEU B 184 5 5 HELIX 14 14 PRO B 192 GLY B 204 1 13 HELIX 15 15 ASP B 208 ALA B 220 1 13
SHEET 1 A 7 GLY A 112 LEU A 115 0 SHEET 2 A 7 VAL A 135 CYS A 138 -1 N SER A 136 O SER A 114 SHEET 3 A 7 PRO A 41 ILE A 44 1 O PRO A 41 N VAL A 135 SHEET 4 A 7 GLY A 53 VAL A 61 -1 O GLY A 53 N ILE A 42 SHEET 5 A 7 GLY A 64 ILE A 71 -1 O GLY A 64 N VAL A 61 SHEET 6 A 7 LEU A 5 ASP A 12 -1 O LEU A 5 N ILE A 71 SHEET 7 A 7 VAL A 149 GLY A 151 -1 N VAL A 149 O GLY A 8 SHEET 1 B 7 GLY B 112 SER B 117 0 SHEET 2 B 7 PHE B 132 CYS B 138 -1 N GLN B 133 O SER B 116 SHEET 3 B 7 PRO B 41 ILE B 44 1 O PRO B 41 N VAL B 135 SHEET 4 B 7 GLY B 53 VAL B 61 -1 O GLY B 53 N ILE B 42 SHEET 5 B 7 GLY B 64 ILE B 71 -1 O GLY B 64 N VAL B 61 SHEET 6 B 7 LEU B 5 VAL B 13 -1 O LEU B 5 N ILE B 71 SHEET 7 B 7 VAL B 149 GLY B 151 -1 N VAL B 149 O GLY B 8
LINK K K B1001 NE2 HIS B 175 1555 1555 2.38 LINK K K B1001 NE2 HIS B 171 1555 1555 2.42 LINK K K B1001 NE2 HIS B 171 1555 6765 2.16 LINK K K B1001 NE2 HIS B 175 1555 6765 3.11
CISPEP 1 SER A 224 PRO A 225 0 -0.43 CISPEP 2 LEU B 34 PRO B 35 0 -0.33 CISPEP 3 SER B 224 PRO B 225 0 0.08
SITE 1 AC1 2 HIS B 171 HIS B 175
CRYST1 53.580 53.580 323.060 90.00 90.00 120.00 P 31 2 1 12
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.018664 0.010775 0.000000 0.00000
SCALE2 0.000000 0.021551 0.000000 0.00000
SCALE3 0.000000 0.000000 0.003095 0.00000